Related Experiment Video
Updated: Feb 26, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Patients' Perception of App-based Educational and Behavioural Interventions for Enhancing Oral Anticancer Medication
Eskinder Eshetu Ali1, Jo Lene Leow2, Lita Chew1,2
1Department of Pharmacy, Faculty of Science, National University of Singapore, Block S4A, 18 Science Drive 4, Singapore, 117543, Republic of Singapore.
Abstract:
Well-designed smartphone apps can potentially help in enhancing adherence to oral anticancer medications (OAMs). The objective of this study was to evaluate patients' perception on inclusion of various adherence-enhancing strategies as features of an app and their interest in using such app. A cross-sectional survey was conducted at the National Cancer Centre Singapore. A structured self-administered questionnaire was used to collect data from patients taking OAMs. Final analysis was based on 409 surveys and most of the respondents were female (291, 71.1%), Chinese (332, 81.2%), married (296, 72.4%) and breast cancer patients (211, 51.6%). Close to two-thirds of respondents rated medication information (65.0%), disease information (60.2%) and side effect self-management (60.2%) features as having the highest level of importance in an adherence app. Three hundred thirty-two (81.2%) of the respondents owned a smartphone, among which 92 (27.7%) reported using health-related apps. From respondents with smartphones, 219 (66.0%) were interested in using an app for OAM adherence. Age 65 and older compared to 21-54 years old (adjusted OR = 0.34; 95% CI = 0.15-0.76) and current use of a health app (adjusted OR = 1.91; 95% CI = 1.07-3.41) were significant predictors of interest to adopt an adherence app. In conclusion, patients value the inclusion of educational and behavioural interventions in adherence apps. Developers of adherence apps should consider including tools for side effect self-management and provision of information to educate patients on their medications and disease condition.
Insights
Smartphone apps can improve oral anticancer medication adherence. Patients prioritize medication/disease information and side effect management features in adherence apps.
Area of Science:
- Oncology
- Digital Health
- Patient Adherence
Background:
- Oral anticancer medications (OAMs) require high adherence for treatment efficacy.
- Smartphone applications offer a potential avenue for enhancing patient adherence to OAMs.
Purpose of the Study:
- To assess patient perceptions of adherence-enhancing strategies within a smartphone app.
- To evaluate patient interest in using such an adherence app.
Main Methods:
- A cross-sectional survey was conducted with 409 patients taking OAMs at the National Cancer Centre Singapore.
- Data collected via a structured, self-administered questionnaire.
- Analysis included demographic factors and patient preferences for app features.
Main Results:
- Most respondents (66.0%) with smartphones were interested in using an adherence app.
- Key desired features included medication information (65.0%), disease information (60.2%), and side effect self-management (60.2%).
- Current health app usage (OR=1.91) and age (older adults less likely) predicted interest in adherence apps.
Conclusions:
- Patients highly value educational and behavioral interventions within adherence apps.
- App developers should prioritize features for side effect management and patient education on medications and disease.
- Smartphone apps show promise for improving oral anticancer medication adherence.
Related Concept Videos
Oral Drug Delivery Systems: Introduction
Drug Therapy
Antianxiety Medications
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Kidney Transplant III: Nursing Management
Bioavailability Enhancement: Drug Permeability Enhancement

